title: Norfloxacin monodose use in patients with cholera in Salta Argentina.
abstract: The use of monodose (800 mg) per os of Norfloxacin was evaluated in 32 patients with cholera at Salvador Mazza's Hospital, Salta, Argentina. It was considered the celerity in negativization of stool culture (100% of cases: 12 hours post administration), it efficiency along time (24/24 controlled patients were negative at 10th day) and MIC of isolated strains (100% of strains were sensitive: range 0.008 to 0.016 micrograms/ml). It was included oral administration of sorbitol 70% in peanut oil in order to study patients at 10th day's control. This method could be an alternative one in the study of asymptomatic carrier. Norfloxacin monodose shows good performance in early negativization of stool culture and it was also effective along the whole observation period, suggesting it could prevent carriage.
authors.affiliation: Hospital de Infecciosas F. J. Muñiz, Municipalidad de la Ciudad de Buenos Aires, Argentina.
authors.forename: A C
authors.initials: AC
authors.lastname: Seijo
authors.forename: M
authors.initials: M
authors.lastname: Fernandez
authors.forename: C
authors.initials: C
authors.lastname: Campos
authors.forename: B E
authors.initials: BE
authors.lastname: Cernigoi
authors.forename: M
authors.initials: M
authors.lastname: Nogueras
authors.forename: J
authors.initials: J
authors.lastname: San Juan
authors.forename: M F
authors.initials: MF
authors.lastname: Torres
authors.forename: O A
authors.initials: OA
authors.lastname: Martino
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001118:Argentina; D002771:Cholera / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009643:Norfloxacin / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D000890:Anti-Infective Agents; D009643:Norfloxacin